Sandoz Hit With Patent Suit Over Skin Condition Drug
A drugmaker, a dermatology lab and New York University slapped Novartis AG unit Sandoz Inc. with a patent infringement suit Wednesday in Delaware over Sandoz's bid for regulatory approval to market...To view the full article, register now.
Already a subscriber? Click here to view full article